India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
An Indian government-approved expert panel has advised the country's drug regulator to approve the import and sale of U.S. drugmaker Eli Lilly's Mounjaro, a
July 01, 2024Your subscription includes
Unlimited Access to All Content from
The Los Angeles Post
An Indian government-approved expert panel has advised the country's drug regulator to approve the import and sale of U.S. drugmaker Eli Lilly's Mounjaro, a
July 01, 2024India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used to treat diabetes and obesity, in 2026, a top government official said
June 28, 2024More than 36% of the 400 drug manufacturing units inspected since last year in India were ordered to be shut, the country's drug regulator said on Thursday,
June 27, 2024Popular Indian spice brand MDH, under scrutiny for alleged contamination in some products, has since 2021 seen an average 14.5% of its U.S. shipments
May 12, 2024A former member of the opposition Congress and an on-and-off ally of Indian Prime Minister Narendra Modi could decide the shape and stability of the next
June 05, 2024Britain's food watchdog has applied extra control measures on all spice imports from India, it said on Wednesday, becoming the first to ramp up scrutiny of all
May 16, 2024New Zealand's food safety regulator on Wednesday said it is investigating possible contamination in spice products of top Indian brands MDH and Everest after
May 15, 2024